Delayed hypersensitivity reaction to cosmetic filler following two COVID-19 vaccinations and infection.

Authors:
Azzouz S; Lanoue D; Champagne K; Genest G.

Journal:
Allergy Asthma Clin Immunol

Publication Year: 2023

DOI:
10.1186/s13223-023-00788-1

PMCID:
PMC10115597

PMID:
37076880

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Allergy Asthma Clin Immunol

Abbreviation: Allergy Asthma Clin Immunol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Acuity of asthma exacerbations in Alberta, Canada is increasing: a population-based study.
Adatia A; Moolji J; Satia I. (2024) - Transparency Score: 3/6
Different expression levels of interleukin-36 in asthma phenotypes.
Li J; Wang Z; Dong H and 3 more (2024) - Transparency Score: 3/6
Inborn errors of immunity in adulthood.
Wang JJF; Dhir A; Hildebrand KJ and 5 more (2024) - Transparency Score: 3/6
Prevalence of asthma in people with type 1 diabetes mellitus: a scoping review.
Kamei JM; Maués RD; de Oliveira Silva G and 5 more (2024) - Transparency Score: 3/6
Resource utilization and cost assessment of a proactive penicillin allergy de-labeling program for …
Lanoue D; Mir A; van Walraven C and 3 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approvalN/A. Consent for publicationWritten consent obtained from patient. Competing interestsNo conflict of interest. Competing interests No conflict of interest."

Evidence found in paper:

"Funding N/A."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025